You are here

I-Mab Biopharma

AbbVie Ends I-Mab Partnership for CD47 Antibody Compounds, Products

BioSpace

Mon, 09/25/23 - 10:04 am

I-Mab Biopharma

Nasal Vaccine Starts Trial to Protect Against Alzheimer's

BioSpace

Tue, 11/16/21 - 10:31 pm

Alzheimer's disease

clinical trials

I-Mab Biopharma

Jiangsu Nhwa Pharmaceutical

I-Mab's IL-6 drug hits goal in ulcerative colitis phase 2

Fierce Biotech

Mon, 04/26/21 - 10:54 am

I-Mab Biopharma

ulcerative colitis

clinical trials

AbbVie has 47 reasons for its $2B cancer immunotherapy partnership with I-Mab

MedCity News

Sun, 09/6/20 - 07:19 pm

I-Mab Biopharma

cancer immunotherapy

AbbVie puts $2B on the table for I-Mab cancer collab as biotech nabs $418M raise

Fierce Biotech

Fri, 09/4/20 - 02:43 pm

I-Mab Biopharma

I-MAB advances repositioned RA drug in early trial to treat COVID-19 cytokine storm

Fierce Biotech

Mon, 06/1/20 - 10:37 am

I-Mab Biopharma

After closing one of China's biggest-ever raises, I-Mab Biopharma nabs $104M Nasdaq IPO

Fierce Biotech

Fri, 01/17/20 - 12:08 pm

I-Mab Biopharma

autoimmune disease

The first biotech IPO of the new decade has landed — and of course it's another cancer drug developer

Endpoints

Mon, 01/6/20 - 10:27 am

Black Diamond Therapeutics

I-Mab Biopharma